In the so-called “Yu Chang case,” in which Chinese Nationalist Party (KMT) lawmakers accused Tsai of wrongdoing in the formation of Yu Chang Biologics Co (宇昌生技股份有限公司) — now known as TaiMed Biologics Inc (中裕新藥股份有限公司) — when she served as vice premier, a senior government official used an altered document to try to discredit Tsai.
Both cases caused concern among international election observers and the fairness of the upcoming presidential election has been called into question, the committee said.



